cromolyn sodium has been researched along with Diabetes Mellitus in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al Ghussein, MA; Bustanji, Y; El-Maraghy, SA; Motawi, TM; Taha, MO | 1 |
| Shi, GP; Wang, J | 1 |
2 other study(ies) available for cromolyn sodium and Diabetes Mellitus
| Article | Year |
|---|---|
Naproxen and cromolyn as new glycogen synthase kinase 3β inhibitors for amelioration of diabetes and obesity: an investigation by docking simulation and subsequent in vitro/in vivo biochemical evaluation.
Topics: Animals; Binding Sites; Cromolyn Sodium; Diabetes Mellitus; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Mice; Molecular Docking Simulation; Naproxen; Obesity; Protein Binding; Protein Conformation | 2013 |
Mast cell stabilization: novel medication for obesity and diabetes.
Topics: Animals; Cromolyn Sodium; Diabetes Mellitus; Insulin Resistance; Ketotifen; Mast Cells; Mice; Obesity; Weight Gain | 2011 |